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Abstract
Background: The aim of the study was to investigate expression of ADAMs (A Disintegrin and A
Metalloproteinase) of host cell origin during cell-cell fusion induced by human parainfluenza virus
type 2 (HPIV2).
Results: Induction of host cell ADAM9 was observed in GMK cells, but the applicability of this
model was restricted by lack of cross-reactivity of the anti-human ADAM8 antibodies with the
corresponding green monkey antigens. HSG cells were not susceptible to HPIV2 virus infection. In
contrast, in human parotid gland HSY cells, a natural host cell for paramyxoviruses, HPIV2 induced
ADAM8 expression. ADAM8 staining increased dramatically over time from 7.9 ± 3% at zero hours
to 99.2 ± 0.8% at 72 hours (p = 0.0001). Without HPIV2 the corresponding percentages were only
7.7% and 8.8%. Moreover, ADAM8 positive cells formed bi- (16.2%) and multinuclear cells (3.5%)
on day one and the corresponding percentages on day three were 15.6% for binuclear and 57.2%
for multinuclear cells.
Conclusion:  ADAM8, well recognized for participation in cell-to-cell fusion especially in
osteoclast formation, is up-regulated upon formation of multinuclear giant cells after HPIV2
induction in HSY cells. The virus-HSY cell system provides a novel experimental model for study
of the molecular mechanism of cell fusion events.
Background
In paramyxovirus-host cell fusion the virion membrane
and host cell membrane are first brought into close con-
tact and docked to each other. This occurs with the help of
the hemagglutinin-neuraminidase on the surface of the
virus, which binds to the sialic acid-containing receptor
on the surface of the host cell. This interaction triggers the
latent fusion protein (F protein) trimers inserted by their
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carboxy-terminal end into the virion membrane to
undergo conformational changes. This exposes their hid-
den amino-terminal hydrophobic fusion peptide
domains. The now exposed hydrophobic viral fusion pep-
tides insert into the host (target) cell membrane. Thus,
they anchor the virion to the host target cell. Two close-by
anchoring fusion proteins then fold, this time so that their
two trimeric membrane-bound hydrophobic domains
(i.e. the transmembrane domain fixed in the virion mem-
brane and the fusion peptide domain fixed in the host cell
membrane) align in an anti-parallel fashion to form a
structurally strong 6-helix bundle. This power stroke
brings the virion membrane and the host cell membrane
together and leads to exoplasmic virus-host cell fusion fol-
lowed by formation and expansion of the initial pore
between the virus and the host cell. Uncoating of the virus
ends up with entrance of the viral RNA and its nucleopro-
teins into the host cell [1]. Thus, the viral fusion protein
helps the viral envelope to fuse directly with the plasma
membrane of the target cell [2].
Compared with the understanding of the virus-host cell
fusion and entry of the virus into host cell (or an artificial
liposome), insight into the molecular mechanisms of the
formation of virally induced syncytia (multikaryons) is at
a rudimentary level. Fusion of the membranes of the
virus-infected cells with those membranes of adjacent
uninfected or infected cells results in the formation of a
giant virus factory, a syncytium, with the additional
advantage from the viral point of view of not destroying
the exploited host cell. Some pioneering studies have
focused on the lipid, glycoprotein and protein composi-
tions of the target cell membranes and their ability to pro-
mote the formation of syncytia [3-5]. Such studies are
hampered by the fact that the lipids, glycoproteins and
proteins and their receptors on the mammalian cell sur-
faces of are much more complex than the most elaborate
virion membranes and their constituents. We hypothe-
sized that, good fusion molecule candidates of mamma-
lian origin, which could contribute to virally induced host
cell-host cell fusion, would be such molecules that have
already been recognized in other, non-virally induced
cell-cell fusion events.
Fusion of gametes to form the zygote cell requires "A Dis-
intergrin and A Metalloproteinase" molecules known as
ADAM1 and ADAM 2 [6,7]; and the myoblast fusion to
myotubes requires ADAM12 [8,9]. Macrophage progeni-
tor cell fusion to osteoclasts seems to require ADAM8
[10], ADAM9 and ADAM12 [11]. We have reported that
ADAM8 [12], ADAM9 [13] and ADAM12 [14] are
involved in the fusion of monocyte/macrophages to for-
eign body giant cells. Some ADAMs (including ADAM8,
ADAM9 and ADAM12) contain a putative fusion peptide
in the cysteine-rich domain that is involved in membrane
fusion in the formation of multinuclear giant cells and
osteoclasts [8-10,15]. A fusion peptide penetrates the lipid
bilayer of the cell. Thus, the anchoring fusion peptide pro-
pels the cell so close to the target cell membrane that the
cell fusion is triggered. We have focused in particular in
ADAM8, whereby it was of interest to clarify whether it
has the potential to fuse, not only macrophages, but also
other cells. Such a system might furthermore provide a
novel method for study of cell fusion in general. Thus,
ADAM8 was selected as the candidate molecule and was
studied for its eventual presence and regulation in virally
induced human cell-cell fusion. It is not known whether
ADAM8 is regulated or utilized by viruses for spreading
their offsprings to uninfected cells and whether this repre-
sents an option for the virus to invade additional cells.
Our working hypothesis was that, human parainfuenza
virus type 2 (HPIV2), typically forming syncyta, might uti-
lize and/or induce transmembrane ADAM8, a protein
linked earlier to the formation of osteoclasts and foreign
body giant cells. To test this hypothesis, we added HPIV2
to green monkey kidney (GMK) cells and to examine
human salivary gland cell lines (HSG and HSY) to study
whether host cell-encoded ADAM8 is involved in the
fusion of target cells. The results led to the insight that the
HPIV2 induced cell fusion system could provide a novel
human cell-based experimental system of study regula-
tion of cell fusion-associated molecules in general.
Results and Discussion
ADAMs in HPIV2-infected GMK cells
Green monkey kidney (GMK) cells are in virological lab-
oratories used for maintaining the HPIV2 stocks. There-
fore, the effects of HPIV2 on GMK cells were studied first.
When these cells were infected by the HPIV2, viral hemag-
glutinin-neuraminidase antigens were found in infected
cells and multinuclear syncytia were formed [16]. In these
preliminary experiments, the eventual involvement of
ADAMs was studied by using affinity purified polyclonal
rabbit anti-human ADAM8 antibodies. The human spe-
cific ADAM8 antibody did not show cross-reactivity with
the corresponding green monkey kidney cell (although
positive sample controls stained in parallel with the GMK
cells were positive), whereby ADAM8 could not be
assessed.
At 2 hours HPIV2 antigens were not yet found in infected
GMK cells (data not shown) and ADAM9 was absent (Fig-
ure 1A, B). On culture day 1 HPIV2 was seen in infected
GMK cells and all the infected and some of the uninfected
GMK cells were ADAM9 positive (Figure 1C). On culture
day 3 HPIV2 had infected most GMK cells and had caused
cytopathic effects including formation of large multinu-
cleated syncytia. The multinuclear giant cells were rela-
tively strongly labeled for ADAM9 (Figure 1D). TheBMC Microbiology 2009, 9:55 http://www.biomedcentral.com/1471-2180/9/55
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positive controls of ADAMs were positive showing that
the immunolabeling protocol used worked acceptably;
also the negative staining controls were negative showing
that the ADAM9 staining results were correctly positive
(data not shown).
This is in line with our previous study demonstrating that
human ADAM9 might as a human protein participate in
the formation of multinuclear osteoclasts and foreign
body giant cells [13]. However, due to the technical limi-
tations of the HPIV2-GMK system (cross-species differ-
ences in the ADAM8 antigen), it was decided that further
attempts be done using target cells of human origin.
ADAM8 expression in the HPIV2 infected HSY cells
HPIV2 infection of GMK cells gave promising results but
ADAM8, our main target of interest, could not be shown
in these monkey cells using anti-human antibodies.
Human submandibular cell line HSG was then used, but
it was not possible to infect HSG cells with HPIV2. No
hemagglutinin-neuraminidase antigens were found in
HSG cells in co-cultures with HPIV2 virus and no syncytia
were formed. As HPIV2 is a paramyxovirus, and the virus
causing mumps (human epidemic parotitis) with clear
preference to human parotid glands, next a human
parotid gland cell line HSY was tried.
In the uninfected HSY cells a very weak ADAM8 signal was
seen (Figure 2A). At 2 hours HPIV2 was not yet found in
HPIV2 infected HSY cell cultures and ADAM8 showed
weak staining (Figure 2B). On culture day one, HPIV2 was
seen inside HSY cells, which usually also showed cytoplas-
mic patches of immunoreactive ADAM8 (Figure 2C). On
culture day three HPIV2 was found in some HSY cells. In
Immunofluorescence double staining of ADAM9 and HPIV2 marker of HPIV2 stimulated GMK cell cultures on culture day 0  (panel A, B), 1 (panel C), 3 (panel D) Figure 1
Immunofluorescence double staining of ADAM9 and HPIV2 marker of HPIV2 stimulated GMK cell cultures on 
culture day 0 (panel A, B), 1 (panel C), 3 (panel D). ADAM9 staining is shown in red and HPIV2 shown in green, 
together with the blue nuclear counterstain of the same field. On culture day 0 HPIV2 did not infect any cells, therefore (A) 
shows only nuclear counterstain, (B) shows only ADAM9 staining, (C, D) overlays show double staining of ADAM9 and HPIV2 
marker on culture days 1 and 3, respectively. Bar = 10 μm.BMC Microbiology 2009, 9:55 http://www.biomedcentral.com/1471-2180/9/55
Page 4 of 7
(page number not for citation purposes)
addition, many large multinucleated cells were seen,
which also were HPIV2 positive. In double label studies
they stained for ADAM8, with a relatively strong signal,
and a non-homogenous, granular and patchy cytoplasmic
distribution (Figure 2D). In morphometric analysis, with-
out HPIV2 stimulation the percentage of ADAM8 positive
cells at 2 hours was 7.7 ± 0.9%, at 24 hours 7.5 ± 0.9% and
at 72 hours 8.8 ± 1.0%. In HPIV2 infected cultures of
human HSY cells the percentage of ADAM8 positive cells
at 0 hour was 7.9 ± 3%, at 2 hours 15.0 ± 6.7% (p = 0.25),
at 24 hours 57.0 ± 11% (p = 0.0719) and at 72 hours 99.2
± 0.8% (p = 0.0001). All HPIV2 infected cells were also
ADAM8 positive. We then calculated the percentages of
ADAM8 and HPIV2 double positive cells and obtained
that way also the number of ADAM8 positive but HPIV2
negative cells (Table 1). Moreover, ADAM8 positive cells
formed also bi- and multinuclear cells. Fusion was seen
already on day one at which time 16.2 ± 1.0% of the cells
were binuclear and 3.5 ± 0.8% were multinuclear (all of
them being ADAM8 positive). On day 3 15.6 ± 2.5% of
the cells were binuclear (and all of them also ADAM8 pos-
itive) and altogether 57.2 ± 3.8% of all cells were multinu-
clear (and all of the also ADAM8 positive) (Figure 3).
Expression of ADAM8 HPIV2 infected cell cultures was
studied using the rabbit anti-human ADAM8 carboxy-ter-
minal antibody as it was reasoned that the antibody rec-
ognizing the intracytoplasmic carboxy-terminal end of the
molecule would provide an idea of the amount of the full-
length ADAM8 molecule, with the amino-terminal
propeptide and metalloproteinase domains, as well as its
amino-terminal end trimmed counterparts. Indeed, in
non-infected HSY cells the proportion of ADAM8-positive
cells was relatively low and stable over time. In contrast,
HPIV2 clearly and dramatically up-regulated ADAM8
expression, which in only 3 days increased from 7.9 to
99.2% (p < 0.001). Apart from this dramatic up-regula-
tion of host cell encoded ADAM8, two other interesting
observations were made in these experiments. First, this
increase in ADAM8 expression was accompanied by the
formation of binuclear cells and very soon also of multi-
nuclear syncytia. By kinetic association between the
increased ADAM8 expression and cell-to-cell fusion it was
concluded to indicate that HPIV2 induces this tentative
host fusion molecule for enhancement of host-host cell
fusion. This conclusion is in part based on the general role
of ADAM8 in such fusion processes in the formation of
osteoclasts [10] and foreign body giant cells [12]. It can
also be asked whether this host-host cell fusion could pro-
vide some survival advantages to the HPIV2 virus. Inter-
estingly, it was noticed that at the beginning of the culture
period most of the ADAM8-positive host cells were nega-
tive for HPIV2 hemagglutinin-neuraminidase antigen
indicating that they were non-infected. However, it is also
conceivable that the detection of nucleocapsid protein,
the most abundant viral protein, would have raised the
number of cells identified as HPIV2-positive. Cells, which
were not immunoreactive for HPIV2, were often seen in
close association to the HPIV2-immunoreactive mononu-
clear, binuclear and multinuclear cells apparently ready to
undergo fusion with their infected partners. The infection
of host cells by HPIV2 triggers some unknown mecha-
nisms which initiate cell fusion process and these mecha-
nisms seem to lead to up-regulation of host cell ADAM8,
which might contribute to the cytopathic cell fusion. This
suggests that HPIV2 utilizes host encoded ADAM8 to
spread from infected to non-infected target cells. On the
cell surface, host cell fusion molecules, like ADAMs, could
cause the HPIV2 infected host cell membrane to fuse with
the neighboring non-infected cells to form syncytia. This
strategy might enable fusion of dozens of non-infected
cells to a giant multi-nuclear cell which means that HPIV2
can use resources of many more cells compared to an
infection of only one cell although "syncytial" infected
cells will lose viability much faster than do "non-syncy-
tial" infected cells. At the same time, this syncytial virus
factory protects against host-derived anti-viral antibodies,
complement and other host defense factors, unable to
penetrate to the host target cell cytoplasm upon virus
reproduction. However, expression of an ADAM8 protein
in mononuclear prefusion cells and multinucleated cells
does not mean that it functions as a fusion protein in this
context although there is evidence for this in human oste-
oclastogenesis [17].
Conclusion
This study demonstrates for the first time the up-regula-
tion of ADAM8 during HPIV2 induced cell fusion. Using
a Trojan horse strategy of this kind HPIV2 can spread effi-
ciently and safely, possibly in part by utilizing the fusion
molecules of the host cells. Mammalian cell fusion has
been studied by others and by us in human monocyte cul-
tures stimulated with receptor activator of nuclear factor
kappa B ligand, which however is quite a time consuming
Table 1: Percentage of positive cell of all the cells (mean ± SEM %)
Day 0 Day 1 Day 3
Percentage of ADAM8+/HPIV2+ cells 0 19.1 ± 2.9 19.3 ± 1.5
Percentage of ADAM8+/HPIV2- cells 15 ± 6.7 37.9 ± 3.6 78.9 ± 1.9BMC Microbiology 2009, 9:55 http://www.biomedcentral.com/1471-2180/9/55
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and complicated system [18,19]. It was therefore the aim
of the present work to assess if HPIV2 infected human
cells have a potential to utilize also host cell fusion mole-
cules in the fusion process as the first step towards the
development of a novel tool for studying fusion of human
cells although the characteristics of this system were not
clarified by this work.
Methods
Cell cultures
GMK, a kidney-derived epithelial-like cell line, is suscepti-
ble to HPIV2 and was maintained in virological laborato-
ries to generate HPIV2 virions. It was obtained from the
Helsinki University Central Hospital laboratory and
maintained in minimal essential medium (MEM, Haart-
Bio Ltd. Helsinki, Finland) containing 10% (v/v) heat-
inactivated foetal bovine serum and 100 μg/l Glutamine-
Penicillin-Streptomycin (HaartBio) in 75 cm2  culture
flasks at 37°C and 5% CO2 incubator [20].
HSG cell line derived from human submandibular gland
[21] and HSY cell line derived from human parotid gland
[22] were cultured at 37°C, 5% CO2-in-air in Dulbecco's
modified Eagle's medium with nutrient mixture F-12
Ham (DMEM/F-12, Sigma, St. Louis, MO) supplemented
Immunofluorescence double staining of ADAM8 and HPIV2 marker of HPIV2 stimulated HSY cell cultures on culture day 0  (panel B), 1 (panel C), 3 (panel D) Figure 2
Immunofluorescence double staining of ADAM8 and HPIV2 marker of HPIV2 stimulated HSY cell cultures on 
culture day 0 (panel B), 1 (panel C), 3 (panel D). ADAM8 staining is shown in red and HPIV2 shown in green (arrow-
heads), together with the blue nuclear counterstain of the same field. Panel A shows the staining of HSY cells that HPIV2 did 
not infect as negative control, therefore (A) only ADAM8 weak staining with nuclear counterstain, (B, C, D) overlay of double 
staining of ADAM8 and HPIV2 marker with blue nuclear counterstain of the same field on culture days 0, 1 and 3, respectively. 
Bar = 10 μm.BMC Microbiology 2009, 9:55 http://www.biomedcentral.com/1471-2180/9/55
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with 10% (v/v) fetal calf serum, 2.2 mM glutamine, 100
U/ml penicillin and 100 μg/ml streptomycin.
Virus infection
HPIV2 was obtained from the Helsinki University Central
Hospital laboratory where it was used as a reference virus.
The virus was grown in the GMK cells according to stand-
ard procedures [23].
Medium was removed when the adherent GMK, HSG or
HSY target cells covered 70–90% of the surface in 75 cm2
cell culture flasks. They were washed with 1 ml culture
medium twice and then exposed to 1.5 μg/ml trypsin at
+37°C and in 5% CO2 for 5 minutes. The detached GMK,
HSG, HSY cells were divided into the 6-well plates, which
1.2 × 106 cells per well. 23 μl HPIV2 primary viral suspen-
sion, containing 2.7 × 107 infective units per milliliter, was
added to each 2.5 ml cell culture well. The cells were har-
vested at zero hours (before addition of HPIV2), at two
hours, on day one and on day three. In parallel, cells cul-
tured without HPIV2 were harvested as controls at zero
and two hours and on one and three days.
Double-immunofluorescence staining
GMK cells cultured on coverslips for 2 hours, 1 day or 3
days were washed in 10 mM phosphate buffered, 150 mM
saline, pH 7.4 (PBS), fixed in pure acetone for 20 minutes
at -20°C and incubated in 1) a mixture of 2 μg/ml poly-
clonal rabbit anti-human ADAM9 IgG (Triple Point Bio-
logics, Forest Grove, OR) and fluorescein isothiocyanate
(FITC) labeled monoclonal mouse anti-HPIV2 hemag-
glunin-neuraminidase IgG1 (Light Diagnostic Respiratory
DFA Viral Screening & Identification Kit, Millipore,
Temecula, CA, USA) for 30 minutes and 2) Alexa Fluor
594-labeled goat anti-rabbit IgG (Molecular Probes,
Eugene, OR) for 30 minutes. Non-immune rabbit IgG and
monoclonal mouse IgG1 of irrelevant specificity were used
at the same concentration instead of the primary antibod-
ies as negative controls. Synovial membrane-like interface
tissue samples collected from the proximal bone-cement
or bone-stem interfaces around aseptically loosened fem-
oral stems during revision total hip replacement opera-
tions were used as positive controls [13]. Coverslips were
mounted using Vectashield Mounting Medium contain-
ing 4', 6-diamidino-2-phenylindole (DAPI, Vector Labo-
ratories, Burlingame, CA) for nuclear staining.
HSY cells cultured on coverslips for 2 hours, one day or
three days were washed in PBS, fixed in pure acetone for
20 minutes at -20°C and incubated in 1) a mixture of
affinity purified rabbit anti-human (carboxy-terminal end
of, proprietary information) ADAM8 IgG (Cedarlane Lab-
oratories Ltd., Hornby, Ontario, Canada) and FITC-
labeled monoclonal mouse anti-HPIV2 IgG1 (Millipore)
for 30 minutes and 2) Alexa Fluor 594-labeled goat anti-
rabbit IgG (Molecular Probes) for 30 minutes. The anti-
body used for ADAM8 staining has been peptide-affinity
purified and does not react with other ADAMs. Coverslips
were mounted using Vectashield Mounting Medium con-
taining DAPI (Vector Laboratories). Non-immune rabbit
IgG and monoclonal mouse IgG1 of irrelevant specificity
were used at the same concentration instead of the pri-
mary antibodies as negative staining controls. Stained
cells were observed using Olympus motorized revolving
AX 70 system microscope (Olympus Optical, Hamburg,
Germany) coupled with 12 bits Sensicam digital image
camera (Sensicam, Kelheim, Germany) and analyzed
using the Analysis Pro 3.0 image analysis and processing
system (Soft-Imaging Software GmbH, Munster, Ger-
many).
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